drugset / Trial / NCT00002308

A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drugs

NCT00002308 ↗

RandomizedSingle-groupDouble-blindTreatment

Summary

To make stavudine (d4T) available to patients with advanced HIV disease for whom no alternative antiretroviral is satisfactory. To study the safety and efficacy of two dose levels in a twice-daily regimen.

Timeline

Start
—
Primary completion
—
Completion
1991-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Stavudine Other / unclassified — —